KIDS · Insider Trading
OrthoPediatrics Corp. Common Stock
Every open-market purchase and sale reported by KIDS officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-11 | Squadron Capital Holdings LLC | 10%+ Owner | Sell | −302,369 | −$6.35M |
| 2026-09-11 | Jennifer N. Pritzker | 10%+ Owner | Sell | −302,369 | −$6.35M |
| 2026-09-10 | David R Pelizzon | Director | Sell | −302,369 | −$6.35M |
| 2026-09-04 | Squadron Capital Holdings LLC | 10%+ Owner | Sell | −22,500 | −$525.38K |
| 2026-09-04 | David R Pelizzon | Director | Sell | −22,500 | −$525.38K |
| 2026-09-04 | Jennifer N. Pritzker | 10%+ Owner | Sell | −22,500 | −$525.38K |
| 2026-09-01 | Squadron Capital Holdings LLC | 10%+ Owner | Sell | −336,831 | −$7.76M |
| 2026-09-01 | David R Pelizzon | Director | Sell | −336,831 | −$7.76M |
| 2026-09-01 | Jennifer N. Pritzker | 10%+ Owner | Sell | −336,831 | −$7.76M |
| 2026-08-26 | Squadron Capital Holdings LLC | 10%+ Owner | Sell | −38,300 | −$943.30K |
| 2026-08-26 | Jennifer N. Pritzker | 10%+ Owner | Sell | −38,300 | −$943.30K |
| 2026-08-26 | David R Pelizzon | Director | Sell | −38,300 | −$943.30K |
| 2026-06-10 | Samuel D Riccitelli | Director | A | +11,436 | — |
| 2026-06-10 | (Reynolds) Marie C Infante | Director | A | +11,436 | — |
| 2026-06-10 | David R Bailey | President and CEO | A | +119,140 | — |
| 2026-06-10 | Bryan W Hughes | Director | A | +11,436 | — |
| 2026-06-10 | Kelly Laine Fischer | Director | A | +11,436 | — |
| 2026-06-10 | Mark C Throdahl | Director | A | +11,436 | — |
| 2026-06-10 | Harold Ruf | Director | A | +11,436 | — |
| 2026-06-10 | George Sinclair Mitchell Dyer | Director | A | +11,436 | — |
| 2026-06-10 | Jimmy Duane McDonald | Director | A | +11,436 | — |
| 2026-06-10 | David R Pelizzon | Director | A | +11,436 | — |
| 2026-05-14 | Daniel J Gerritzen | General Counsel and Secretary | G | −2,479 | — |
| 2026-03-17 | David R Bailey | President and CEO | Sell | −19,535 | −$336.98K |
| 2026-03-17 | Fred Hite | COO and CFO | MIXED | +64,412 | −$224.13K |
| 2026-03-17 | Joseph W Hauser | Pres. Trauma & Def. Correction | MIXED | +57,104 | −$148.28K |
| 2026-03-17 | Gregory A Odle | President of Scoliosis | MIXED | +38,947 | −$145.47K |
| 2026-03-17 | Daniel J Gerritzen | General Counsel and Secretary | MIXED | +38,766 | −$148.59K |
| 2025-12-30 | David R Bailey | President and CEO | G | −1,600 | — |
| 2025-11-12 | Kelly Laine Fischer | Director | A | +4,345 | — |
| 2025-08-25 | Fred Hite | COO and CFO | Buy | +5,076 | +$98.53K |
| 2025-05-28 | Jimmy Duane McDonald | Director | A | +8,401 | — |
| 2025-05-28 | George Sinclair Mitchell Dyer | Director | A | +8,401 | — |
| 2025-05-28 | Bryan W Hughes | Director | A | +8,401 | — |
| 2025-05-28 | David R Pelizzon | Director | A | +8,401 | — |
| 2025-05-28 | Samuel D Riccitelli | Director | A | +8,401 | — |
| 2025-05-28 | Harold Ruf | Director | A | +8,401 | — |
| 2025-05-28 | Mark C Throdahl | Director | A | +8,401 | — |
| 2025-05-28 | (Reynolds) Marie C Infante | Director | A | +8,401 | — |
| 2025-05-28 | Terry D Schlotterback | Director | A | +8,401 | — |
| 2025-03-18 | Gregory A Odle | President of Scoliosis | MIXED | +33,414 | −$133.22K |
| 2025-03-18 | Joseph W Hauser | Pres. Trauma & Def. Correction | MIXED | +46,869 | −$131.76K |
| 2025-03-18 | Fred Hite | COO and CFO | MIXED | +56,899 | −$160.17K |
| 2025-03-18 | David R Bailey | President and CEO | MIXED | +90,876 | −$164.57K |
| 2025-03-18 | Daniel J Gerritzen | General Counsel and Secretary | MIXED | +33,463 | −$132.01K |
| 2024-12-30 | David R Bailey | President and CEO | G | −1,500 | — |
| 2024-08-22 | Daniel J Gerritzen | General Counsel and Secretary | Sell | −10,000 | −$293.00K |
| 2024-06-11 | Gregory A Odle | President of Scoliosis | A | +34,901 | — |
| 2024-06-11 | Fred Hite | COO and CFO | A | +57,018 | — |
| 2024-06-11 | Daniel J Gerritzen | General Counsel and Secretary | A | +34,901 | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| David R Pelizzon | Director | 6,246,148 | $203.12M |
| Jennifer N. Pritzker | 10%+ Owner | 6,212,664 | $202.04M |
| Squadron Capital Holdings LLC | 10%+ Owner | 6,201,764 | $201.68M |
| David R Bailey | President and CEO | 417,160 | $13.57M |
| Fred Hite | COO and CFO | 277,477 | $9.02M |
| Mark C Throdahl | Director | 201,814 | $6.56M |
| Joseph W Hauser | Pres. Trauma & Def. Correction | 194,767 | $6.33M |
| Gregory A Odle | President of Scoliosis | 187,735 | $6.11M |
| Daniel J Gerritzen | General Counsel and Secretary | 147,054 | $4.78M |
| Harold Ruf | Director | 39,084 | $1.27M |
| Bryan W Hughes | Director | 32,663 | $1.06M |
| Samuel D Riccitelli | Director | 31,859 | $1.04M |
| (Reynolds) Marie C Infante | Director | 31,202 | $1.01M |
| Terry D Schlotterback | Director | 29,165 | $948.45K |
| Jimmy Duane McDonald | Director | 24,568 | $798.95K |
| George Sinclair Mitchell Dyer | Director | 24,568 | $798.95K |
| Kelly Laine Fischer | Director | 15,781 | $513.20K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the KIDS quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.